Home > Insider Trading > Filing (0001140361-15-017795)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221590	Jacques Jean Bienaime	C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-30	908	$51.26	252,159	No	4	A	Direct
Common Stock	Acquisiton	2015-05-01	23,218	$6.46	56,476	No	4	M	Indirect	Shares held by Bienaime Family Trust
Common Stock	Disposition	2015-05-01	23,218	$114.98	33,258	No	4	S	Indirect	Shares held by Bienaime Family Trust
Common Stock	Disposition	2015-05-01	3,505	$114.98	248,654	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	M	Indirect	Shares held by Bienaime Family Trust
No	4	S	Indirect	Shares held by Bienaime Family Trust
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2015-04-01	23,218	$0.00	23,218	$6.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-11-11	2015-05-10	No	4	M	Indirect

Footnotes

The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2014 to April 30, 2015.
Trade made pursuant to a 10b5-1 plan executed October 28, 2014.
The reporting person an his spouse act as trustees for the Bienaime Family Trust
The price in column 4 is an average weighted price. The price actually received ranged from $112.80 to $119.50. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
Original option grant vests 6/48th on November 11, 2005, and 1/48th on the 11th day of every month thereafter.
Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.